The Lancet Child & Adolescent Health

Mixed Results from Study of Probiotic Added to Oral Immunotherapy (OIT)

Dave Bloom - 2022/02/11

The addition of the probiotic did not improve the effectiveness of OIT but did enhance tolerability of the treatment.

Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...

News Wire ~ 3rd Party Press Release - 2020/07/21

Peanut-allergic patients treated with Palforzia showed desensitization to peanut protein with a predictable safety profile at nine months

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

Dave Bloom - 2017/08/21

Exciting news of lasting peanut tolerance four years after Probiotic + Peanut OIT treatment.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: The Lancet Child & Adolescent Health

Mixed Results from Study of Probiotic Added to Oral Immunotherapy (OIT)

Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results